SMMT
Summit Therapeutics Inc
$14.01
+7.11% (+$0.93)
Volume
9.83M
52W High
$30.98
52W Low
$12.55
Market Cap
$16.93B
Next Earnings Report
Last Reported
May 7, 2026 Missed
Actual: -$0.18
vs. Consensus: -$0.12
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
+5.42%
5-Day:
+10.50%
Q1 2026
Apr 30, 2026
1-Day:
-24.91%
5-Day:
-18.27%
Q4 2025
Mar 12, 2026
1-Day:
+4.27%
5-Day:
+2.52%
Q4 2025
Feb 23, 2026
1-Day:
+0.19%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'23 | $235,000 | -6.0% | -100.4% | -6,720.9% | -$14.7M |
| Q4'22 | $705 | -99.7% | -10,000.0% | -10,000.0% | -$19.2M |
| Q3'22 | $220,000 | -83.2% | 100.0% | -7,700.0% | -$21.4M |
| Q2'22 | $235,000 | +312.3% | 82.2% | -5,400.9% | -$16.8M |
| Q1'22 | $250,000 | +30.2% | 100.0% | -8,863.2% | -$21.4M |
| Q4'21 | $251,000 | +35.7% | 100.0% | -10,000.0% | -$25.7M |
| Q3'21 | $1.3M | +623.2% | 100.0% | -1,488.6% | -$19.6M |
| Q2'21 | $57,000 | -66.5% | 100.0% | -10,000.0% | -$24.4M |
Company Information
Symbol
SMMT
Company
Summit Therapeutics Inc
Market Cap
$16.93B